| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/04/2000 | US6046204 Treatment of immunosuppressive, autoimmune, inflammatory, proliferative and hyperproliferative diseases including cancer, and of cutaneous manifestations of immunologically mediated diseases, for example rheumatoid arthritis, lupus |
| 04/04/2000 | US6046203 Useful for the treatment of various memory dysfunctions characterized by a decreased cholinergic function such as alzheimer's disease; also inhibit monoamine oxidase and hence are useful as antidepressants |
| 04/04/2000 | US6046202 Use of thiazolidinedione derivatives in the treatment of insulin resistance |
| 04/04/2000 | US6046200 Compositions having neuroprotective and analgesic activity |
| 04/04/2000 | US6046199 Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives |
| 04/04/2000 | US6046198 Hemoregulatory compounds |
| 04/04/2000 | US6046197 Non-peptide amide compounds; stimulate hematopoiesis and may be useful for treatment of viral, fungal and bacterial infectious diseases |
| 04/04/2000 | US6046196 Antispastic use of triazolo-pyridazine derivatives |
| 04/04/2000 | US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 04/04/2000 | US6046193 Treatment of attention-deficit/hyperactivity disorder |
| 04/04/2000 | US6046192 Phenylethanolaminotetralincarboxamide derivatives |
| 04/04/2000 | US6046191 Combination |
| 04/04/2000 | US6046190 For inhibiting retroviral proteases such as human immunodeficiency virus |
| 04/04/2000 | US6046189 Thienopyridine derivatives and their use |
| 04/04/2000 | US6046188 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 04/04/2000 | US6046187 Use of glucocorticosteroids in methods and formulations for prolonging and/or reactivating local anesthesia or local anesthesia previously induced by a local anesthetic agent |
| 04/04/2000 | US6046186 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 04/04/2000 | US6046185 6,7-oxygenated steroids and uses related thereto |
| 04/04/2000 | US6046184 Medicament for treating obesity and improving lipid metabolism |
| 04/04/2000 | US6046183 Synergistic mixture of finasteride and doxazosin |
| 04/04/2000 | US6046182 Steroid carbamates as potentiating agents |
| 04/04/2000 | US6046180 NAALADase inhibitors |
| 04/04/2000 | US6046177 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 04/04/2000 | US6046176 Chitin extract for treatment of skin disease |
| 04/04/2000 | US6046175 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 04/04/2000 | US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae |
| 04/04/2000 | US6046172 Hydrolytically processed oligodeoxyribonucleotides and their pharmaceutical compositions |
| 04/04/2000 | US6046161 Use of hemoglobin in the treatment of cardiogenic shock |
| 04/04/2000 | US6046159 Formulations and methods of reducing toxicity of antineoplastic agents |
| 04/04/2000 | US6046049 Compound 8 to 30 nucleobases in length targeted to 3' untranslated region of nucleic acid which encodes human phosphatidyl inositol 3' kinase p110 delta isoform found in leukocytes; diagnosis, treatment of related diseases |
| 04/04/2000 | US6046030 For the treatment of neurological disorders such as alzheimer's disease, multiple sclerosis and abnormal neural development; endocrine disorders such as diabetes; and heart disease, among others and diagnostic assays for such |
| 04/04/2000 | US6046022 Methods and compositions employing red rice fermentation products |
| 04/04/2000 | US6046009 Diagnosis and treatment of glaucoma |
| 04/04/2000 | US6045832 Use of DACEE and Derivatives for treating viral diseases |
| 04/04/2000 | US6045831 Nuclear inhibitor I-92 and its use for the production of a medicament |
| 04/04/2000 | US6045829 Having increased rate and uniformity of absorption in vivo |
| 04/04/2000 | US6045828 Mixture of crystalline, hydrophilic carrier and freeze dried, single phase particles comprising a biologically active component and a lipid component having a phase transition temperature below 37 degrees c |
| 04/04/2000 | US6045827 Treatment of equine laminitis |
| 04/04/2000 | US6045826 Antioxidant/antiaging medicinal or cosmetic mixture for skin disorder prophylaxis |
| 04/04/2000 | US6045825 Plantago major and Piper methysticum compound for use in treating a tobacco or nicotine habit |
| 04/04/2000 | US6045824 Sustained-release liposomal anesthetic compositions |
| 04/04/2000 | US6045822 Protein kinase c inhibitor, antitumor agent having stability in blood |
| 04/04/2000 | US6045820 Iodinated strong base anion exchange resin antiseptic particles attached to a carrier material whereby the antiseptic leaves no halogen residue in sterilized fluid or bodily wound sites |
| 04/04/2000 | US6045819 Substance containing health-promoting component and process for the production thereof |
| 04/04/2000 | US6045815 An antifungal composition including a dipolar aprotic solvent and an aqueous secondary solvent |
| 04/04/2000 | US6045808 Method for removing high boiling solvents from drug formulations by vacuum drying |
| 04/04/2000 | US6045789 Bystander effect tumoricidal therapy by expressing an HSV-tk gene |
| 04/04/2000 | US6045778 Stabilized medicinal aerosol solution formulations |
| 04/04/2000 | US6045773 Method of detecting cyclooxygenase-2 |
| 04/04/2000 | US6045398 Battery accepting unit and battery pack |
| 04/04/2000 | CA2246162C Modulation of th1/th2 cytokine expression by ribavirin.rtm. and ribavirin.rtm. analogs in activated t-lymphocytes |
| 04/04/2000 | CA2204739C Macrocyclic lactone compounds and their production process |
| 04/04/2000 | CA2173878C Polynucleotide for treating systemic lupus erythematosus |
| 04/04/2000 | CA2155009C Prevention and treatment of myocardial failure |
| 04/04/2000 | CA2136607C Pharmaceutical powder composition containing non-ionic cellulose ether derivative and a chitin-derived polymer |
| 04/04/2000 | CA2107432C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present |
| 04/04/2000 | CA2078662C 4-desoxy-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof |
| 04/04/2000 | CA2063729C Biodegradable system for regenerating the periodontium |
| 04/04/2000 | CA2006975C Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith |
| 04/04/2000 | CA2002540C Dna sequence coding for the human ix factor or a similar protein, expression vector, transformed cells, process for the preparation of ix factor and products obtained |
| 04/04/2000 | CA1340948C Peptidylaminodiols |
| 04/04/2000 | CA1340943C Azacyclic compounds and their preparation and use |
| 04/04/2000 | CA1340940C Peptidylaminodiols |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017366A2 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug |
| 03/30/2000 | WO2000017354A1 Human isre-binding protein |
| 03/30/2000 | WO2000017351A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 03/30/2000 | WO2000017346A2 Hairpin hybridizer molecules for modulation of gene expression |
| 03/30/2000 | WO2000017233A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 03/30/2000 | WO2000017232A2 Regulatory protein from human keratinocytes |
| 03/30/2000 | WO2000017212A1 Organophosphorous compounds and use thereof |
| 03/30/2000 | WO2000017211A1 Phosphonic acids derivatives as inhibitors of ptp-1b |
| 03/30/2000 | WO2000017204A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | WO2000017202A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 03/30/2000 | WO2000017200A1 Tetrahydropyridoethers |
| 03/30/2000 | WO2000017198A1 3-bicycloindole compounds as 5-ht1d ligands |
| 03/30/2000 | WO2000017195A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/30/2000 | WO2000017192A1 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 03/30/2000 | WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 03/30/2000 | WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/30/2000 | WO2000017184A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors |
| 03/30/2000 | WO2000017182A1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
| 03/30/2000 | WO2000017176A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 03/30/2000 | WO2000017175A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017173A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 03/30/2000 | WO2000017167A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 03/30/2000 | WO2000017166A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 03/30/2000 | WO2000017165A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 03/30/2000 | WO2000017164A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 03/30/2000 | WO2000017161A1 Cyclic ester or amide derivatives |
| 03/30/2000 | WO2000017159A1 Arylsulfonanilide ureas |
| 03/30/2000 | WO2000017158A1 Urokinase inhibitors |
| 03/30/2000 | WO2000017147A1 5,6-dihydronaphthalenyl derivatives having retinoid-like activity |
| 03/30/2000 | WO2000017133A2 Lta4 hydrolase inhibitors |
| 03/30/2000 | WO2000016814A1 Medicinal aerosol formulation |
| 03/30/2000 | WO2000016808A2 Antibody directed enzyme prodrug therapy (edept) with glucoronidase |
| 03/30/2000 | WO2000016804A1 METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN |
| 03/30/2000 | WO2000016798A1 Use of non-peptidyl compounds for the treatment of insulin related ailments |
| 03/30/2000 | WO2000016794A1 Neuroimmunophilins for selective neuronal radioprotection |